Trials / Completed
CompletedNCT05846906
Effect of Oral Sildenafil Citrate on Improvement of Endometrial Thickness
Oral Sildenafil Citrate: a Potential Approach for Improvement of Endometrial Thickness and Treatment of Unexplained Infertility in Women
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Beni-Suef University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
One hundred thirty women with unexplained infertility participated in a prospective clinical study. Patients were assigned at random to one of two groups. The first group (n=65) served as the study group and was given clomiphene citrate 50 mg (Tecnovula®, Techno Pharmaceuticals, Egypt) and sildenafil (Respatio®, Pharma right group, Egypt) 20 mg tablets. The second group (n=65) served as a control and received a placebo tablet in addition to the standard treatment of clomiphene citrate 50 mg (Tecnovula®). A transvaginal ultrasound was performed on all of the patients to assess ovulation.
Detailed description
One hundred thirty women with unexplained infertility participated in a prospective clinical study. Patients were assigned at random to one of two groups. The first group (n=65) served as the study group and was given clomiphene citrate 50 mg (Tecnovula®, Techno Pharmaceuticals, Egypt) orally twice daily from the second day of their cycle through the seventh day and sildenafil (Respatio®, Pharma right group, Egypt) 20 mg tablets from the end of menstruation through ovulation. The second group (n=65) served as a control and received a placebo tablet in addition to the standard treatment of clomiphene citrate 50 mg (Tecnovula®). A transvaginal ultrasound was performed on all of the patients to assess ovulation, follicle count, and pregnancy. Consequences, including miscarriage, ectopic pregnancy, and multiple pregnancies, were monitored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil Citrate | oral sildenafil (Respatio® 20mg ) |
| DRUG | Clomiphene Citrate 50mg | used for ovionulation induct |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2022-04-30
- Completion
- 2022-04-30
- First posted
- 2023-05-06
- Last updated
- 2023-05-30
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05846906. Inclusion in this directory is not an endorsement.